Speakers
| Kirsten Axelsen | American Enterprise Institute, Visiting Fellow
kjacarmel@gmail.com 202-862-5920 |
| Lovisa Gustafsson | The Commonwealth Fund, Assistant Vice President |
| Kristi Martin | Waxman Strategies, Managing Director |
| James C. Robinson | University of California Berkley, Leonard D. Schaeffer Professor of Health Economics and Director of Berkeley Center for Health Technology |
Experts and Analysts
| Gerard Anderson | Johns Hopkins University Center for Hospital Finance and Management, Director and Professor of Health Policy and Management
ganderson@jhu.edu 410-955-3241 |
| Juliette Cubanski | Kaiser Family Foundation, Associate Director of the Program on Medicare Policy
jcubanski@kff.org 650-854-9400 |
| Stacie Dusetzina | Vanderbilt University Medical Center, Associate Professor of Health Policy and Ingram Associate Professor of Cancer Research
s.dusetzina@vanderbilt.edu 615-875-9281 |
| Adam Fein | Drug Channels Institute, Chief Executive Officer |
| Lance Grady | Avalere Health, Vice President of Market Access and Reimbursement
lgrady@avalere.com 202-459-6276 |
| Tara O’Neill-Hayes | American Action Forum, Deputy Director of Health Care Policy thayes@americanactionforum.org 202-441-9745 |
| Jack Hoadley | Georgetown University Health Policy Institute, Research Professor Emeritus
jfh7@georgetown.edu 202-687-1055 |
| Benedic Ippolito | American Enterprise Institute, Research Fellow in Economic Policy Studies
Benedic.Ippolito@aei.org 202-862-5828 |
| Elizabeth Jungman | The Pew Charitable Trusts, Director of Public Health Programs
ejungman@pewtrusts.org 202-540-6443 |
| Mark Miller | Arnold Ventures, Executive Vice President of Health Care |
| Ameet Sarpatwari | Harvard Medical School, Instructor in Medicine; Brigham Women’s Hospital, Assistant Director of the Program on Regulation, Therapeutics, And Law in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine
asarpatwari@partners.org 443-622-7908 |
| Gillian Woollett
|
Avalere Health, Senior Vice President of the FDA Practice
gwoollett@avalere.com 202-207-1300 |
Government
| Anna Abram | U.S. Food and Drug Administration, Deputy Commissioner for Policy, Planning, Legislation and Analysis |
| John Brooks | U.S. Department of Health and Human Services, Senior Adviser to the Secretary for Drug Pricing Reform
John.Brooks@cms.hhs.gov 202-690-5400 |
| John Coster | Center for Medicaid and CHIP Services, Director, Division of Pharmacy
John.Coster@cms.hhs.gov 410-786-3000 |
| Kate Goodrich | Centers for Medicare & Medicaid Services, Chief Medical Officer and Director of the Center for Clinical Standards and Quality
kate.goodrich@cms.hhs.gov 410-786-5533 |
| Paul Masi | Medicare Payment Advisory Commission, Assistant Director
pmasi@medpac.gov 202-220-3700 |
Stakeholders
| Lauren Aronson | Campaign for Sustainable Drug Pricing (CSRxP), Executive Director
laronson@mc-dc.com 202-403-8621 |
| Holly Campbell | Pharmaceutical Research and Manufacturers of America, Deputy Vice President of Public Affairs |
| Robert Dubois | National Pharmaceutical Council, Chief Science Officer and Executive Vice President
rdubois@npcnow.org 202-827-2079 |
| Jonathan Heafitz
|
Pharmaceutical Care Management Association, Vice President of Federal Affairs
jheafitz@pcmanet.org 202-756-5735 |
| Eleanor Perfetto | National Health Council, Senior Vice President of Strategic Initiatives
eperfetto@nhcouncil.org 202-360-1681 |
| Natalie Pons
|
OptumRx, General Counsel of Policy and Regulatory Affairs
natalie.pons@optum.com 952-205-6103 |
| Leigh Purvis | AARP Health Policy Institute, Director of Health Services Research
lpurvis@aarp.org 202-434-3890 |
| Murray Ross | Kaiser Permanente Institute for Health Policy, Director |
| Lori Shoaf | Blue Cross Blue Shield Association, Managing Director of Federal Relations |
| Judith Stein | Center for Medicare Advocacy, Executive Director
jstein@medicareadvocacy.org 860-456-7790 |